Cannabis has been increasingly used as a sleep aid by individuals struggling with insomnia and other sleep-related issues. While its immediate effects on promoting sleep are well-documented, concerns remain about potential next-day impairments.
A recent study has shed light on this issue, suggesting that using marijuana before sleep may have minimal, if any, adverse effects on next-day performance. This blog explores the findings and their implications for both infrequent cannabis users and the broader community.
A recent study has shed light on this issue, suggesting that using marijuana before sleep may have minimal, if any, adverse effects on next-day performance. This blog explores the findings and their implications for both infrequent cannabis users and the broader community.
Study Overview
Here are the key aspects of the study
Purpose
Investigate the next-day effects of cannabis on cognitive and psychomotor functions, and driving performance.
Publication
Published in the journal Psychopharmacology.
Research Institutions
Conducted by Macquarie University, University of Sydney, Royal Prince Alfred Hospital, Griffith University, and Johns Hopkins University.
Participants
- 20 adults with physician-diagnosed insomnia.
- Participants were infrequent marijuana users.
Substances Tested
- Cannabis oil containing 10 mg THC and 200 mg CBD.
- Placebo as a control.
Study Design
- Randomized, placebo-controlled crossover design.
- Each participant experienced both the placebo and the cannabis oil in different sessions.
Assessments
- Cognitive tests within two hours of waking.
- Driving performance 10 hours after administration using a fixed-base driving simulator.
- Subjective effects measured at baseline and at multiple intervals (30 minutes, 10 hours, 12 hours, 14 hours, 16 hours, and 18 hours post-administration).
Key Findings
The study revealed several important outcomes
- There were no significant differences in cognitive function between the THC/CBD and placebo groups.
- 27 out of 28 cognitive and psychomotor function tests showed no next-day impairment.
- A minor reduction in accuracy (1.4%) was noted in the Stroop color and word test, but this was not clinically meaningful as both groups had high accuracy (>97%).
- No significant differences were found in simulated driving performance between the THC/CBD and placebo groups.
- This aligns with prior findings suggesting that driving-related skills recover within approximately 8 hours after ingesting 20 mg of oral THC.
- Participants reported no significant differences in feelings of sedation, alertness, anxiety, or other subjective effects between the THC/CBD and placebo groups.
- The use of cannabis the night before did not lead to notable next-day impairments in mood or subjective experiences.
Comparison with Other Sleep Aids
| Criteria | Cannabis (THC/CBD) | Sedative-Hypnotics (e.g., Benzodiazepines, Zopiclone) |
|---|---|---|
| Next-Day Cognitive Impairment | No significant impairment | Significant next-day drowsiness and impaired function |
| Next-Day Driving Performance | No significant differences in simulated driving | Known to impair driving performance |
| Hangover Effects | No significant hangover effects | Residual effects impacting next-day performance |
| Safety and Efficacy | Considered safer with fewer next-day effects | Higher risk of next-day impairment |
| User Preferences | Preferred for sleep issues; better outcomes and fewer side effects | Less preferred due to next-day impairments and side effects |
Next-Day Cognitive Impairment
- Cannabis (THC/CBD): No significant impairment
- Sedative-Hypnotics (e.g., Benzodiazepines, Zopiclone): Significant next-day drowsiness and impaired function
Next-Day Driving Performance
- Cannabis (THC/CBD): No significant differences in simulated driving
- Sedative-Hypnotics (e.g., Benzodiazepines, Zopiclone): Known to impair driving performance
Hangover Effects
- Cannabis (THC/CBD): No significant hangover effects
- Sedative-Hypnotics (e.g., Benzodiazepines, Zopiclone): Residual effects impacting next-day performance
Safety and Efficacy
- Cannabis (THC/CBD): Considered safer with fewer next-day effects
- Sedative-Hypnotics (e.g., Benzodiazepines, Zopiclone): Higher risk of next-day impairment
User Preferences
- Cannabis (THC/CBD): Preferred for sleep issues; better outcomes and fewer side effects
- Sedative-Hypnotics (e.g., Benzodiazepines, Zopiclone): Less preferred due to next-day impairments and side effects
Detailed Analysis
In-depth examination of the study’s results provides further insights
- Most cognitive tests, including those assessing attention, working memory, and speed of information processing, showed no significant next-day effects from THC/CBD.
- The minor reduction in accuracy observed in the Stroop color and word test (1.4%) was deemed not clinically meaningful, as participants maintained high accuracy levels (>97%).
- No significant difference in accuracy was observed on the harder incongruent condition of the Stroop-Word Test, which requires matching the meaning of the word rather than its printed color.
- For comparison, alcohol hangover states produce greater interference on the Stroop-Word Test but not on the Stroop-Color Test, highlighting the minimal impact of THC/CBD on cognitive interference
- Simulated driving tests conducted 10 hours after cannabis administration showed no significant differences between the THC/CBD and placebo groups.
- These findings are consistent with previous studies indicating that driving-related skills in occasional cannabis users recover within approximately 8 hours after ingesting 20 mg of oral THC.
Participant Experience
Participants’ experiences provided valuable context to the study’s findings
Comparison of Placebo and THC/CBD Groups
- Both groups showed similar results in terms of cognitive performance and driving ability, reinforcing the conclusion that a single oral dose of 10 mg THC (with 200 mg CBD) does not impair next-day functions.
- Subjective effects were measured at various intervals, including baseline, 30 minutes, and 10 to 18 hours post-administration, ensuring a comprehensive assessment of potential residual effects.
Context and Implications
The study’s findings have several important implications
For Infrequent Cannabis Users
- Individuals who infrequently use cannabis and take it as a sleep aid may not experience significant next-day cognitive or driving impairments.
- This supports the notion that occasional use, especially in controlled doses, can be a safe option for those needing help with sleep.
Public Health and Safety
- These results can inform public health guidelines and safety regulations, particularly regarding cannabis use for medical purposes.
- The study alleviates some concerns about next-day performance, especially in safety-sensitive tasks like driving.
Medical and Therapeutic Use
- The findings contribute to the broader understanding of cannabis as a potential therapeutic aid, particularly for sleep disorders.
- Medical practitioners might consider these results when prescribing cannabis for sleep issues, balancing benefits against potential risks.
Limitations and Future Research
While the study provides valuable insights, several limitations need to be addressed
Related Research
Recent studies provide additional context and support for these findings
Neurocognitive Effects
- A study published last December found minimal acute impact on cognitive function among medical marijuana patients with chronic health conditions.
- Another report in March linked marijuana use to lower odds of subjective cognitive decline (SCD), with users reporting less confusion and memory loss compared to non-users.
Marijuana and Laziness
A 2022 study found no difference in apathy or reward-based behavior between regular cannabis users and non-users, challenging the stereotype of cannabis-induced laziness.
Sleep Quality
- A Washington State University study highlighted that cannabis users with sleep issues preferred it over other sleep aids, reporting better outcomes and fewer side effects the next morning.
- Other 2023 studies involving individuals with chronic health conditions and neurological disorders also reported improved sleep quality with cannabis use.
Summary of Key Findings
The recent study provides reassuring evidence that using cannabis as a sleep aid does not significantly impair next-day cognitive function or driving performance in infrequent users. This suggests that cannabis can be a viable alternative to traditional sedatives, offering improved sleep quality with fewer next-day side effects. However, the study’s limitations, including its small sample size and focus on a single dose, highlight the need for further research.
Future studies should explore the effects of repeated dosing and varying THC/CBD ratios to better reflect real-world use. Additionally, long-term research is essential to understand the cumulative impacts of regular cannabis use on daily functioning. Overall, these findings contribute to the growing body of evidence supporting the therapeutic use of cannabis, particularly for sleep disorders, and can help inform public health guidelines and medical practices.
Ready to find the
perfect strain for your needs?
Discover the benefits of a personalized cannabis experience. Locate a marijuana specialist in FL, CT & NY today to explore tailored recommendations and find the perfect strains for your needs.
